Biliary Cysts
Biliary cysts are congenital cystic dilatations of the intrahepatic and/or extrahepatic bile ducts that predispose to cholangitis, stone formation, and cholangiocarcinoma.
Biliary cysts are congenital cystic dilatations that can occur singly or multiply throughout the biliary tree — both intrahepatic and extrahepatic bile ducts [1][2].
- The term "choledochal cyst" was coined in 1959, originally referring only to extrahepatic bile duct dilatations [1].
- "Choledocho-" = common bile duct (Greek: choledochos = "receiving bile"); "cyst" = fluid-filled sac (Greek: kystis = bladder/sac).
- So the name literally means "a cystic sac of the common bile duct."
- The nomenclature was expanded in 1977 to include intrahepatic cysts and further refined in 2003 to incorporate the concept of an abnormal pancreaticobiliary junction (APBJ) [1].
- The modern umbrella term "biliary cyst" is preferred because it captures the full spectrum — extrahepatic, intrahepatic, or both.
| Feature | Detail |
|---|---|
| Sex | Female predominance (M:F ≈ 1:3–4) [1] |
| Ethnic predilection | Biliary cysts and APBJ are especially common in Asians (incidence ~1 in 1,000 in Japan vs. ~1 in 100,000–150,000 in Western populations) [1] |
| Age at presentation | Majority present before age 10 (~60% diagnosed in childhood) [1][2] |
| Adult diagnosis | Up to 50% of patients may not be diagnosed until adulthood — often discovered incidentally on imaging or when complications (cholangitis, pancreatitis, malignancy) develop [1] |
| Incidence trend | Increasing detection in adults due to widespread use of cross-sectional imaging (CT, MRCP, USG) |
High Yield
Think of biliary cysts as a disease of young Asian females — but remember that a substantial proportion present in adulthood, often with complications. In Hong Kong, always keep biliary cysts in your differential for unexplained biliary dilatation in a young patient.
3. Anatomy and Function of the Biliary System (Foundation)
To understand biliary cysts, you must first understand the normal anatomy they distort.
- Intrahepatic bile ducts → drain bile produced by hepatocytes.
- Right and Left Hepatic Ducts → join at the hilum to form the Common Hepatic Duct (CHD).
- CHD + Cystic Duct → form the Common Bile Duct (CBD) (~7–8 cm long, < 6 mm diameter normally).
- CBD + Main Pancreatic Duct → enter the duodenum at the Ampulla of Vater, surrounded by the Sphincter of Oddi.
- The CBD and pancreatic duct normally join within the duodenal wall (intramural segment), forming a very short common channel (< 5 mm) controlled by the Sphincter of Oddi.
- The Sphincter of Oddi prevents reflux of duodenal content and pancreatic juice into the biliary tree.
- Transports bile (containing bile salts, bilirubin, cholesterol, phospholipids) from the liver to the duodenum for fat digestion and waste excretion.
- The gallbladder stores and concentrates bile between meals.
4. Etiology
Biliary cysts can be congenital (the vast majority) or rarely acquired [1].
| Congenital | Acquired | |
|---|---|---|
| Mechanism | Abnormal embryological development of the biliary epithelium | Post-surgical (e.g., post-cholecystectomy), post-inflammatory |
| Proportion | > 95% | Rare |
| Key association | APBJ, fibrocystic liver disease | Prior biliary surgery/instrumentation |
4.2 The Central Aetiological Theory: Abnormal Pancreaticobiliary Junction (APBJ)
This is the dominant aetiological concept you must understand:
APBJ is present in 70–90% of patients with biliary cysts [1].
- APBJ = the pancreatic duct joins the CBD > 1 cm proximal to the Ampulla of Vater (i.e., outside the duodenal wall) [1].
- This creates a long common channel that lies outside the regulatory influence of the Sphincter of Oddi.
The pathophysiology is elegant and logical:
- Loss of sphincteric control → The Sphincter of Oddi normally prevents reflux. When the junction is proximal (outside the duodenal wall), the sphincter cannot control the long common channel.
- Pancreatic juice reflux into the biliary tree → Pancreatic enzymes (lipase, phospholipase A₂, trypsin, elastase) are activated and directly contact biliary epithelium.
- Chemical damage to biliary epithelium → Chronic inflammation, epithelial destruction, and weakening of the bile duct wall.
- Cystic dilatation → The weakened, inflamed bile duct wall progressively dilates under normal intraluminal pressure → forming a cyst.
- Malignant transformation → Chronic inflammation and epithelial turnover → metaplasia → dysplasia → cholangiocarcinoma.
- During embryological development, the biliary epithelium undergoes a solid cord phase followed by recanalization (vacuolization).
- Congenital cysts may result from unequal proliferation of embryologic biliary epithelial cells before bile duct canalization is complete [1].
- This leads to areas of ductal weakness and dilatation.
Tying it Together
Think of two insults:
- Structural weakness from abnormal embryological development.
- Chemical insult from reflux of pancreatic juice through APBJ.
Both contribute, and APBJ is the stronger, more clinically relevant mechanism — especially for malignant risk.
In Hong Kong and East Asia, biliary cysts are significantly more common than in the West. Relevant associations include:
- APBJ — more common in Asian populations (genetic/developmental predisposition) [1].
- Parasitic infection (Clonorchis sinensis — transmitted by consumption of raw/undercooked freshwater fish 淡水魚) — causes chronic biliary inflammation that may synergistically worsen outcomes in patients with pre-existing biliary cysts [3][4].
- Recurrent pyogenic cholangitis (RPC) (the "Hong Kong disease") — shares overlapping pathology with biliary cysts (intrahepatic stone formation, stricturing, biliary stasis) [4].
Hong Kong Relevance
For HKUMed exams, always mention:
- APBJ as the dominant aetiology.
- The malignant risk (cholangiocarcinoma).
- Clonorchis sinensis as a regional parasitic association.
- RPC as a related biliary condition common in Hong Kong.
This is the universally used classification system. Most commonly Type I [2].
| Type | Description | Frequency | Key Points |
|---|---|---|---|
| Type I | Fusiform or saccular dilatation of the extrahepatic bile duct (CBD) | 50–80% (most common) | Subclassified into Ia (cystic), Ib (focal segmental), Ic (fusiform/diffuse). Highest malignancy risk with Type Ic. |
| Type II | Diverticulum (true diverticulum) of the extrahepatic bile duct | 2–3% | A side-pocket protruding from the CBD wall. Rare. |
| Type III | Choledochocele — cystic dilatation of the intraduodenal (intramural) portion of the distal CBD | 1–5% | Protrudes into the duodenal lumen. "Choledocho-" = bile duct, "-cele" = swelling/herniation. Lowest malignancy risk. |
| Type IV | Multiple cysts | 15–35% | IVa: Extrahepatic + intrahepatic (more common, higher malignancy risk). IVb: Multiple extrahepatic only. |
| Type V | Caroli disease — multiple saccular or cystic dilatations of the intrahepatic bile ducts | ~20% | Caroli disease = isolated intrahepatic cystic dilatation. Caroli syndrome = Caroli disease + congenital hepatic fibrosis. Associated with autosomal recessive polycystic kidney disease (ARPKD). |
Exam Essentials
- Type I = most common (~50–80%).
- Type IVa = second most common; involves both intrahepatic and extrahepatic ducts.
- Type V (Caroli disease) = purely intrahepatic; associated with congenital hepatic fibrosis and ARPKD.
- Types I and IV carry the highest malignancy risk.
- Type III (choledochocele) has the lowest malignancy risk and may be managed with endoscopic sphincterotomy rather than excision.
5.1 Caroli Disease vs. Caroli Syndrome
| Feature | Caroli Disease | Caroli Syndrome |
|---|---|---|
| Bile duct changes | Multiple saccular intrahepatic dilatations | Same as Caroli disease |
| Hepatic fibrosis | Absent | Present (congenital hepatic fibrosis) |
| Renal association | Variable | Strongly associated with ARPKD |
| Portal hypertension | Absent | May develop (due to hepatic fibrosis) |
| Inheritance | Autosomal recessive | Autosomal recessive |
| Gene | PKHD1 (fibrocystin/polyductin) | PKHD1 |
- Think of Caroli syndrome as the more severe form on a disease spectrum — biliary cysts + hepatic fibrosis + renal cysts.
- "Caroli" — named after Jacques Caroli, French gastroenterologist who described the condition.
6. Pathophysiology — Consequences of Biliary Cysts
Understanding the pathophysiology of biliary cysts explains every clinical feature and complication:
- Cystic dilatation creates a "sump" where bile pools and stagnates instead of flowing freely to the duodenum.
- Consequence: Stone formation (choledocholithiasis), bacterial colonization, cholangitis.
- Activated pancreatic enzymes continuously damage the cyst epithelium.
- Consequence: Chronic inflammation, epithelial hyperplasia, malignant transformation.
- The cyst epithelium undergoes a metaplasia–dysplasia–carcinoma sequence analogous to Barrett's oesophagus.
- Risk of cholangiocarcinoma:
- Overall lifetime risk: 10–30% in untreated biliary cysts.
- Risk increases with age (especially after 20 years of age).
- Highest in Type I and Type IVa cysts.
- Also elevated in patients with APBJ even without overt cystic dilatation.
- Cysts can compress adjacent structures (CBD, hepatic ducts, portal vein).
- Consequence: Obstructive jaundice, secondary biliary cirrhosis (if chronic), portal hypertension.
- Stagnant bile is an excellent culture medium.
- Consequence: Recurrent cholangitis, liver abscess.
- In APBJ, the long common channel allows not only pancreatic-to-biliary reflux but also biliary-to-pancreatic reflux.
- Bile reflux into the pancreatic duct → activation of pancreatic enzymes within the pancreas → acute pancreatitis.
- Thin-walled cysts (especially in neonates) can rupture, leading to bile peritonitis.
7. Clinical Features
| Children (< 10 years) | Adults |
|---|---|
| More likely to present with the classic triad | Classic triad present in only ~20% |
| Abdominal mass more common | Abdominal pain dominant |
| Jaundice common | Complications often the presenting feature (cholangitis, pancreatitis, malignancy) |
Classic triad: Jaundice + Abdominal pain + Abdominal mass [1][2]
The classic triad is present in only about 20–30% of adults but is more common in children. Don't rely on the full triad for diagnosis.
| Symptom | Pathophysiological Basis |
|---|---|
| Jaundice | Cyst causes obstruction of bile flow → conjugated hyperbilirubinaemia → bilirubin deposits in skin and sclerae → yellow discolouration. May be intermittent (partial obstruction) or progressive (if malignancy develops). |
| Abdominal pain | Typically RUQ or epigastric. Caused by: (1) distension of the cyst wall; (2) secondary cholangitis; (3) pancreatitis from APBJ-mediated reflux; (4) biliary colic from stone formation within the cyst. |
| Abdominal mass | A large cystic dilatation (especially Type I) can be palpable as a smooth, non-tender (or mildly tender) RUQ mass, particularly in thin children. |
| Pruritus | Cholestasis → bile salts retained in blood → deposit in skin → stimulate itch receptors (C-fibres). Often accompanies jaundice. |
| Fever | Indicates secondary infection — ascending cholangitis. Biliary stasis → bacterial colonization → systemic inflammatory response. May present as Charcot's triad (fever + jaundice + RUQ pain). |
| Nausea and vomiting | (1) Biliary obstruction reflexively stimulates vagal afferents → nausea. (2) Associated pancreatitis. (3) Duodenal compression by large cysts. |
| Weight loss | Chronic biliary obstruction → impaired fat absorption (bile salts don't reach duodenum) → steatorrhoea and caloric loss. Also suggests malignant transformation. |
| Pancreatitis symptoms | Epigastric pain radiating to the back, worse after meals — from APBJ-mediated biliary/pancreatic reflux. |
| Sign | Pathophysiological Basis |
|---|---|
| Jaundice (icteric sclerae, yellow skin) | Conjugated hyperbilirubinaemia from biliary obstruction. Scleral icterus detectable at bilirubin > 35–50 µmol/L because scleral elastin has high affinity for bilirubin. |
| Palpable RUQ mass | Large extrahepatic cyst or hepatomegaly from intrahepatic cysts. Smooth, cystic, may be mildly tender. In neonates, may be the sole presenting sign. |
| RUQ tenderness | Cyst distension, cholangitis, or associated cholecystitis. If positive Murphy's sign → think superimposed cholecystitis. |
| Hepatomegaly | Intrahepatic cysts (Type IVa, V) → liver enlargement. Chronic biliary obstruction → secondary biliary cirrhosis → hepatomegaly (early) or shrunken liver (late). |
| Fever + rigors | Ascending cholangitis — stasis allows Gram-negative organisms (E. coli, Klebsiella) to proliferate → systemic bacteraemia → fever with rigors. |
| Signs of chronic liver disease (spider naevi, palmar erythema, ascites) | If long-standing biliary obstruction has led to secondary biliary cirrhosis (especially in Type IVa or V with congenital hepatic fibrosis in Caroli syndrome). |
| Courvoisier-negative gallbladder | The gallbladder is typically not distended because the cystic duct insertion is usually into or proximal to the cyst; the obstruction is intrinsic rather than distal. Contrast with periampullary tumours where the gallbladder is palpably distended (Courvoisier's Law). |
| Peritoneal signs (guarding, rebound tenderness) | Rare — suggests cyst rupture with bile peritonitis (chemical peritonitis from leaked bile) or perforation of a superimposed empyema. |
- May present with obstructive jaundice mimicking biliary atresia.
- Palpable abdominal mass.
- Acholic (pale) stools + dark urine.
- Must differentiate from biliary atresia — imaging (USG → MRCP) is essential.
| Type | Typical Presentation |
|---|---|
| I | Classic triad in children. In adults: RUQ pain, jaundice, cholangitis. |
| II | Often incidental finding. Can present as acute abdomen if diverticulum twists or becomes infected. |
| III (Choledochocele) | Often asymptomatic. May cause recurrent pancreatitis or duodenal obstruction. |
| IVa | Similar to Type I but more complex — intrahepatic involvement means recurrent cholangitis, hepatolithiasis, and higher malignancy risk. |
| V (Caroli) | Recurrent cholangitis is the hallmark. Hepatolithiasis. If Caroli syndrome → signs of portal hypertension and renal disease (ARPKD). |
8. Key Associations and Related Conditions
This is the most critical association:
- Associated with increased risk of cholangiocarcinoma (CC) especially patients with Type I and IV biliary cysts and those with APBJ [1][3].
- Fibrocystic liver disease leads to cholangiocarcinoma by biliary stasis, chronic inflammation from reflux of pancreatic juice, abnormalities in bile salt transporter proteins resulting in unstable bile content or deconjugation of carcinogens previously conjugated in the liver [3].
- Risk increases with age — this is why prophylactic surgical excision is recommended even in asymptomatic patients.
- The malignancy can arise within the cyst itself or in any part of the biliary tree (including residual bile duct after incomplete excision).
- Choledochal cysts and abnormal pancreaticobiliary tract are listed as risk factors for gallbladder carcinoma [5].
- This is because APBJ affects the entire biliary epithelium, including the gallbladder.
- Biliary cysts (especially Type IVa and V) share pathological features with RPC: intrahepatic dilatation, stricturing, and stone formation [4].
- In Hong Kong, biliary cysts and RPC can co-exist, particularly with Clonorchis sinensis infection.
| Feature | Detail |
|---|---|
| Definition | Congenital cystic dilatation of biliary tree |
| Most common type | Type I (50–80%) |
| Key association | APBJ (70–90%) |
| Classic triad | Jaundice + RUQ pain + abdominal mass |
| Most important complication | Cholangiocarcinoma (10–30% lifetime risk) |
| Demographics | Young Asian females; majority present < 10 years |
| Investigation of choice | USG (initial) → MRCP (anatomical detail) |
| Definitive treatment | Radical excision of cyst + Roux-en-Y hepaticojejunostomy |
High Yield Summary
Must-know points for biliary cysts:
- Definition: Congenital cystic dilatations of the biliary tree (intra- and/or extrahepatic).
- Epidemiology: Female predominance (1:3–4), common in Asians, most diagnosed before age 10.
- Aetiology: APBJ present in 70–90% → allows pancreatic juice reflux → epithelial damage → cyst formation and malignant transformation.
- Todani Classification: Type I (most common, ~50–80%), Type IVa (2nd most common), Type V = Caroli disease.
- Classic triad: Jaundice + abdominal pain + abdominal mass (more common in children; only ~20–30% of adults).
- Malignancy risk: 10–30% lifetime risk of cholangiocarcinoma, highest in Types I and IVa, risk increases with age.
- Hong Kong relevance: APBJ common in Asians; Clonorchis sinensis adds synergistic risk; RPC is a related condition.
- Caroli disease = Type V = intrahepatic cystic dilatation. Caroli syndrome = + congenital hepatic fibrosis + ARPKD.
- Type III (choledochocele) has the lowest malignancy risk.
- Treatment (preview): Radical excision + Roux-en-Y hepaticojejunostomy to prevent cholangiocarcinoma.
Active Recall - Biliary Cysts (Definition, Epidemiology, Aetiology, Classification, Clinical Features)
[1] Senior notes: felixlai.md (Biliary cysts section) [2] Senior notes: maxim.md (Choledochal cyst section) [3] Senior notes: felixlai.md (Cholangiocarcinoma etiology section) [4] Senior notes: maxim.md (Recurrent pyogenic cholangitis section); felixlai.md (RPC section) [5] Senior notes: felixlai.md (Gallbladder cancer risk factors section); maxim.md (Gallbladder carcinoma section)
Differential Diagnosis of Biliary Cysts
The differential diagnosis of a biliary cyst revolves around a fundamental clinical question: what else can cause cystic/dilated structures in or around the biliary tree, or produce the same symptom complex (jaundice + RUQ pain + abdominal mass)?
To reason through this systematically, let's think about what biliary cysts actually look like to the clinician and on imaging:
- On imaging: A cystic dilatation of the bile duct (intra- or extrahepatic).
- Clinically: Some combination of obstructive jaundice, RUQ pain, palpable mass, cholangitis, and/or pancreatitis.
We must therefore differentiate biliary cysts from conditions that mimic either their imaging appearance or their clinical presentation — or both.
I find it most useful to split the differential into two axes:
A. Conditions that mimic cystic biliary dilatation on imaging (the "what else could that cyst be?" question).
B. Conditions that present with a similar clinical syndrome (jaundice ± RUQ pain ± mass ± cholangitis).
A. Conditions Mimicking Cystic Biliary Dilatation on Imaging
These are conditions that can look like a "cyst" in the biliary region on USG, CT, or MRCP:
- Why it mimics: In neonates, both biliary atresia and biliary cysts present with prolonged neonatal jaundice, dark urine, and pale stools [6]. On USG, biliary atresia shows a contracted gallbladder and triangular cord sign (fibrous remnant of extrahepatic duct), which must be distinguished from a dilated cystic duct in choledochal cyst [6].
- How to differentiate:
- Biliary atresia → no visible bile ducts / small/absent gallbladder / triangular cord sign at porta hepatis.
- Biliary cyst → visible cystic dilatation of the bile duct; gallbladder often present.
- E-HIDA scan (hepatobiliary iminodiacetic acid): In biliary atresia, there is absence of isotope in the intestine (no biliary excretion). In biliary cyst, isotope accumulates in the cyst and may still reach the intestine (unless completely obstructed) [6].
- Operative cholangiogram is the gold standard for biliary atresia [6].
Neonatal Jaundice — The Critical DDx
In a neonate with conjugated hyperbilirubinaemia, the two most important surgical diagnoses to differentiate are biliary atresia (needs Kasai procedure within 60 days) and choledochal cyst (needs excision). Getting this wrong has devastating consequences. USG is the first-line imaging for both. Remember: biliary atresia = contracted GB, triangular cord sign; choledochal cyst = cystic dilatation of bile duct.
- Why it mimics: A cyst in the head of the pancreas (e.g., intraductal papillary mucinous neoplasm (IPMN), mucinous cystic neoplasm, serous cystadenoma, or pseudocyst) can be adjacent to or compress the distal CBD, mimicking a distal choledochal cyst (Type III) on imaging [7].
- How to differentiate:
- Pancreatic pseudocyst: History of pancreatitis, thick wall, no epithelial lining (hence "pseudo-"), arises from pancreatic parenchyma not from the bile duct wall.
- IPMN: Communicates with the pancreatic duct (not the bile duct), seen on MRCP as grape-like cystic dilatations of the pancreatic duct.
- MRCP clearly delineates whether the cyst arises from the biliary tree or the pancreatic duct [2].
- Why it mimics: Simple hepatic cysts are extremely common and can be located near the hilum, mimicking intrahepatic biliary cysts (Type IVa or V). Hydatid cysts (Echinococcus granulosus) can also appear as large cystic structures in the liver.
- How to differentiate:
- Simple hepatic cysts: Do not communicate with the biliary tree. On MRCP, there is no connection to bile ducts. Thin-walled, anechoic on USG.
- Hydatid cysts: May show daughter cysts, membrane detachment ("water lily sign"), or calcification. Echinococcus serology positive. Travel history (sheep-farming regions).
- Biliary cysts (Type V / Caroli): Directly communicate with intrahepatic bile ducts — this is the key distinguishing feature on MRCP. May show the "central dot sign" on CT (portal vein radicle surrounded by dilated duct).
- Why it mimics: These are rare true neoplastic cysts of the biliary epithelium. They appear as large, multiloculated cystic masses within the liver, mimicking Type IVa or V biliary cysts.
- How to differentiate:
- Cystadenoma: Multiloculated with internal septae, mural nodules, mucin-secreting epithelium. Predominantly in middle-aged women.
- On MRCP: Does not show the saccular ductal communication pattern of Caroli disease.
- Biopsy/resection shows ovarian-type stroma (in the mucinous subtype).
- Key point: Any biliary cyst with mural nodularity or solid components should raise concern for cystadenoma/cystadenocarcinoma or malignant transformation within a choledochal cyst.
- Why it mimics: Any cause of distal CBD obstruction (choledocholithiasis, pancreatic head carcinoma, periampullary carcinoma, chronic pancreatitis) can cause upstream CBD dilatation that may look fusiform, mimicking a Type I biliary cyst [8][9].
- How to differentiate:
- Age: Biliary cysts are congenital and typically present in young patients; malignant obstruction presents in the elderly.
- Imaging: In distal obstruction, the dilatation tapers to a point of obstruction (the "cut-off" sign). In a true biliary cyst, the cyst has a defined wall and the duct calibre changes abruptly at the cyst margins.
- APBJ: Present in biliary cysts (70–90%), absent in reactive dilatation.
- CBD > 8 mm on USG suggests dilatation [9]; but true biliary cysts are typically much larger and more globular.
- Post-cholecystectomy or post-ERCP sphincterotomy can cause mild CBD dilatation (up to 10 mm) that is physiological, not a cyst [4].
- Why it mimics: A duplication cyst of the second part of the duodenum can appear adjacent to the distal CBD and mimic a Type III choledochal cyst (choledochocele).
- How to differentiate:
- Duplication cyst: Has a muscular wall with intestinal mucosa. Does not communicate with the bile duct on MRCP.
- Choledochocele: Communicates with the CBD and protrudes into the duodenal lumen.
- EUS (endoscopic ultrasound) can distinguish the layers of the cyst wall.
- Why it mimics: A massively distended gallbladder (hydrops from cystic duct obstruction) can appear as a large cystic RUQ mass, mimicking a large Type I choledochal cyst on quick USG assessment.
- How to differentiate:
- Hydrops: The cyst is clearly the gallbladder (connects to cystic duct, fundus projects inferiorly). Contains mucoid/clear fluid. Cystic duct stone may be visible.
- Biliary cyst: The cyst is the bile duct itself; the gallbladder is a separate structure.
- MRCP unambiguously resolves this.
B. Conditions Mimicking the Clinical Syndrome
These conditions produce overlapping symptoms (jaundice, RUQ pain, fever, mass) but are NOT cystic dilatations of the bile duct:
| Feature | Choledocholithiasis | Biliary Cyst |
|---|---|---|
| Age | Middle-aged/elderly | Young (< 10 years typically) |
| Pain pattern | Colicky or constant RUQ, associated with fatty meals | Chronic/recurrent, not meal-related |
| Jaundice | Intermittent or acute | Intermittent or progressive |
| Mass | No palpable mass | Palpable cystic mass (children) |
| USG | Stone in CBD ± dilated CBD | Cystic dilatation of the duct itself |
| MRCP | Filling defect in CBD | Fusiform/saccular cyst ± APBJ |
- Presents with Charcot's triad: fever + jaundice + RUQ pain (present in ~2/3 of patients) [3].
- However, acute cholangitis is a complication of biliary cysts, not an alternative diagnosis. If a young patient presents with cholangitis, always ask: why is this young person getting cholangitis? — and consider an underlying biliary cyst or APBJ.
- Presents with RUQ pain, fever, positive Murphy's sign.
- Distinguished from biliary cysts by: USG showing gallbladder wall thickening (> 3 mm), pericholecystic fluid, gallstones in GB. The bile duct itself is not cystically dilated.
- Pain > 6 hours (vs. biliary colic < 6 hours) [10].
- CHD obstruction caused by extrinsic compression from an impacted stone in Hartmann's pouch/cystic duct [11].
- Can present with jaundice + RUQ pain + palpable gallbladder (an exception to Courvoisier's Law) [11].
- How to differentiate from biliary cyst:
- Mirizzi: Gallstone impacted in cystic duct/Hartmann's pouch with external compression of CHD. USG shows dilatation above the level of gallbladder neck with abrupt change to normal CBD below [11].
- Biliary cyst: Intrinsic cystic dilatation of the bile duct itself. No impacted stone in the cystic duct.
- MRCP resolves the distinction definitively.
- Cholangiocarcinoma is a complication of biliary cysts (10–30% lifetime risk) but also enters the DDx when a biliary cyst patient develops new symptoms.
- Perihilar cholangiocarcinoma (Klatskin tumour) can cause hilar stricturing that mimics a biliary cyst on initial imaging [5].
- Red flags for malignant transformation within a known biliary cyst: New-onset weight loss, progressive painless jaundice, rising CA 19-9, solid mural nodules within the cyst on imaging.
- Risk factors for cholangiocarcinoma include: PSC, RPC, choledochal cysts, Caroli's disease, Lynch syndrome, Clonorchis sinensis, Thorotrast [5].
- "Hong Kong disease" — recurrent bacterial cholangitis with intrahepatic pigment stones and intrahepatic biliary obstruction (strictures) [4].
- Shares features with biliary cysts: intrahepatic ductal dilatation, recurrent cholangitis, left lobe predilection.
- How to differentiate:
- RPC: Acquired condition. Intrahepatic stone disease with stricture-dilatation pattern. Brown pigment stones formed de novo in bile ducts. Left intrahepatic ducts predominantly. Middle-aged onset. History of parasitic exposure.
- Biliary cyst: Congenital. Defined cystic dilatation. APBJ present. Presents younger.
- CT in RPC: Central dilated bile ducts with peripheral tapering, left lobe predilection, liver atrophy [4].
- Chronic progressive disorder characterized by inflammation, fibrosis and stricturing of bile ducts [12].
- Can cause intrahepatic and extrahepatic ductal changes that mimic biliary cysts on imaging.
- How to differentiate:
- PSC: Strong association with ulcerative colitis. Shows "beading" pattern (alternating strictures and dilatations) on MRCP. p-ANCA positive. No APBJ. Middle-aged males.
- Biliary cyst: Congenital. Discrete cystic dilatation (not beading). APBJ present. Young females.
- Autoimmune destruction of small intralobular bile ducts → chronic cholestasis [13].
- Presents with pruritus, fatigue, cholestatic LFTs.
- Distinguished from biliary cysts by: AMA positive, no cystic dilatation on imaging, extreme female predominance (90–95%), middle-aged.
- Painless progressive obstructive jaundice in the elderly is malignant biliary obstruction until proven otherwise [8].
- Can cause dilated CBD mimicking Type I biliary cyst.
- Distinguished by: age (elderly), weight loss, Courvoisier's sign positive (palpable non-tender gallbladder in painless jaundice) [14], pancreatic mass on CT, CA 19-9 elevated.
- Pyogenic or amoebic liver abscess can appear as a cystic hepatic lesion on USG.
- Distinguished by: fever, leukocytosis, elevated inflammatory markers, thick irregular wall with internal debris (not clear fluid), no communication with bile ducts.
- Listed as a differential for infected choledochal cysts [3].
- Biliary cysts with APBJ can present with pancreatitis. Conversely, pancreatitis from any cause can produce a pseudocyst that mimics a biliary cyst.
- Elevated serum amylase/lipase, clinical context, and MRCP showing the origin of the cyst (bile duct vs. pancreas) differentiate the two.
| Condition | Key Distinguishing Features from Biliary Cyst |
|---|---|
| Biliary atresia | Neonate; no visible bile duct; contracted GB; triangular cord sign; absent intestinal isotope on HIDA |
| Pancreatic cyst/pseudocyst | Arises from pancreas not bile duct; communicates with pancreatic duct; history of pancreatitis |
| Simple hepatic cyst | No communication with bile ducts; thin-walled; incidental; asymptomatic |
| Hydatid cyst | Daughter cysts; serology positive; travel history; no biliary communication |
| Biliary cystadenoma | Multiloculated; mural nodules; septations; middle-aged women |
| CBD dilatation (distal obstruction) | Tapering to obstruction point; older age; identifiable distal cause |
| Duodenal duplication cyst | Muscular wall; no biliary communication; EUS confirms intestinal layers |
| Choledocholithiasis | Filling defect in CBD; older patient; no APBJ; no cystic wall |
| Acute cholangitis | Is a complication, not a differential per se; investigate for underlying cause |
| Cholecystitis | GB wall thickening; pericholecystic fluid; Murphy's sign; bile duct normal |
| Mirizzi syndrome | Stone in Hartmann's pouch; extrinsic compression of CHD; no intrinsic cyst |
| Cholangiocarcinoma | Solid mass; stricturing; older patient; rising CA 19-9; may arise within a cyst |
| RPC | Acquired; pigment stones; stricture-dilatation pattern; left lobe; middle-age |
| PSC | UC association; beading on MRCP; p-ANCA; no APBJ |
| PBC | AMA positive; small duct disease; no cystic dilatation; middle-aged women |
| Pancreatic head CA | Elderly; painless jaundice; Courvoisier positive; pancreatic mass |
| Liver abscess | Fever; thick wall; debris; no ductal communication |
High Yield Summary — Differential Diagnosis of Biliary Cysts
When confronted with a cystic biliary lesion:
- Age: Young → biliary cyst, biliary atresia (neonate). Old → malignant obstruction, pancreatic cyst.
- APBJ present? → Strongly favours biliary cyst.
- Does the cyst communicate with the bile duct? → Yes = biliary cyst or Caroli disease. No = hepatic cyst, hydatid, pancreatic cyst.
- Acquired vs. congenital: History of pancreatitis (pseudocyst), surgery (post-op dilatation), parasites (RPC).
- MRCP is the single most useful investigation to resolve the differential — it delineates ductal anatomy, cyst communication, and APBJ in one study.
High Yield
The most important differential in neonates is biliary atresia (Kasai procedure needed within 60 days). The most important differential in adults is malignant transformation within the cyst (cholangiocarcinoma) or malignant biliary obstruction mimicking a cyst. Always think: is this a true congenital cyst, or reactive dilatation from obstruction?
Active Recall - Differential Diagnosis of Biliary Cysts
References
[1] Senior notes: felixlai.md (Biliary cysts section) [2] Senior notes: maxim.md (Choledochal cyst section) [3] Senior notes: felixlai.md (Acute cholangitis section) [4] Senior notes: maxim.md (Recurrent pyogenic cholangitis section); felixlai.md (RPC section) [5] Senior notes: maxim.md (Cholangiocarcinoma section); felixlai.md (Cholangiocarcinoma section) [6] Senior notes: maxim.md (Hepatobiliary conditions — paediatric section) [7] Senior notes: maxim.md (Pancreatic cyst section) [8] Lecture slides: Malignant biliary obstruction.pdf; Senior notes: maxim.md (Obstructive jaundice section) [9] Senior notes: maxim.md (Choledocholithiasis section); felixlai.md (Choledocholithiasis section) [10] Senior notes: maxim.md (Acute cholecystitis section); felixlai.md (Acute cholecystitis section) [11] Senior notes: maxim.md (Mirizzi syndrome section); felixlai.md (Mirizzi syndrome section) [12] Senior notes: felixlai.md (Primary sclerosing cholangitis section) [13] Senior notes: felixlai.md (Primary biliary cholangitis section) [14] Senior notes: felixlai.md (Pancreatic cancer section)
Unlike conditions such as acute cholangitis (which has codified Tokyo Guidelines criteria) or acute cholecystitis (Tokyo criteria with defined scoring), biliary cysts do not have a formal "diagnostic criteria" scoring system. The diagnosis is primarily imaging-based, supported by clinical context and biochemistry.
That said, the diagnosis of a biliary cyst requires establishing three things:
- Presence of a cystic dilatation that communicates with the biliary tree.
- Classification of the cyst type (Todani).
- Assessment for APBJ and exclusion of malignancy.
Let me walk you through the diagnostic approach logically, from bedside to operating theatre.
Key Diagnostic Principle
The diagnosis of a biliary cyst is made when imaging demonstrates a cystic dilatation that communicates with the biliary tree (distinguishing it from hepatic cysts, pancreatic cysts, or other non-biliary cystic lesions). MRCP is the test of choice for diagnosing and evaluating biliary cysts [1]. USG is the initial diagnostic modality [2]. CT determines extent [2].
The approach follows a stepwise logic: Clinical suspicion → Bloods → Initial imaging (USG) → Definitive imaging (MRCP) → Pre-operative planning (CT ± ERCP) → Operative confirmation.
The Three-Investigation Triad for Biliary Cysts
Think of it as: USG (Diagnostic) → MRCP (Anatomy) → CT (Extent) [2]. This is the framework from the senior notes and is exactly how you should answer an exam question about investigating a suspected biliary cyst.
Investigation Modalities — Detailed Breakdown
1. Biochemical Tests (Blood Investigations)
Blood tests in biliary cysts are often normal in uncomplicated cases. They become abnormal when there are complications (cholangitis, pancreatitis, malignancy). Here is what to order and why:
| Finding | Significance | Pathophysiological Basis |
|---|---|---|
| Normal | Uncomplicated biliary cyst | No active infection or inflammation |
| Leukocytosis (↑ WBC with neutrophil predominance) | Complicated by acute cholangitis [1] | Biliary stasis → bacterial colonization → systemic inflammatory response → bone marrow releases neutrophils |
| Thrombocytopenia | If planning for invasive procedure (ERCP) [15] | Check platelet count to assess bleeding risk before instrumentation |
| Pancytopenia | If secondary biliary cirrhosis has developed | Chronic biliary obstruction → cirrhosis → portal hypertension → hypersplenism → destruction of all cell lines |
| Finding | Significance | Pathophysiological Basis |
|---|---|---|
| Serum liver tests are often normal in patients with biliary cysts [1] | Uncomplicated, non-obstructing cyst | Small cysts may not significantly obstruct bile flow |
| Hyperbilirubinaemia (↑ conjugated bilirubin) | Biliary obstruction | Cyst compresses or obstructs bile duct → conjugated bilirubin cannot be excreted into duodenum → backs up into blood |
| Cholestatic pattern (↑ ALP, ↑ GGT) [1] | Biliary obstruction | ALP is concentrated on the canalicular membrane of hepatocytes; when bile flow is obstructed, ALP is induced and "leaks" into serum. GGT confirms hepatobiliary origin of ALP elevation (vs. bone). |
| ↑ AST/ALT | Hepatocellular injury from chronic obstruction | Prolonged cholestasis → secondary hepatocyte damage → transaminase leak |
Why does obstructive jaundice cause a cholestatic pattern? Because ALP and GGT are enzymes located on the biliary canalicular membrane. When bile cannot flow (obstruction), there is back-pressure on the canaliculi, inducing synthesis and release of these enzymes into the bloodstream. This is fundamentally different from hepatocellular damage (where AST/ALT are released from damaged hepatocytes).
| Finding | Significance | Pathophysiological Basis |
|---|---|---|
| ↑ PT/INR | Coagulopathy due to Vitamin K deficiency from decreased absorption of fat-soluble vitamins due to obstructive jaundice [15] | Bile salts don't reach the duodenum → fat malabsorption → fat-soluble vitamins (A, D, E, K) not absorbed → Vitamin K is essential for hepatic synthesis of clotting factors II, VII, IX, X → coagulopathy |
Clinical Pearl
Always check clotting before any invasive biliary procedure (ERCP, PTC, surgery). If PT is prolonged, give IV Vitamin K (phytomenadione) and recheck — if it corrects, the coagulopathy is from cholestasis (Vitamin K deficiency). If it doesn't correct, there is hepatocellular dysfunction (the liver can't make clotting factors even with adequate Vitamin K substrate).
| Finding | Significance | Pathophysiological Basis |
|---|---|---|
| ↑ Serum amylase level if complicated by acute pancreatitis [1] | Concurrent pancreatitis | APBJ allows biliary-to-pancreatic reflux → activation of pancreatic enzymes within the pancreas → autodigestion → amylase/lipase leak into blood |
| Normal | No concurrent pancreatitis | — |
| Marker | Role | Interpretation |
|---|---|---|
| CA 19-9 | Screen for cholangiocarcinoma within the cyst | CEA and CA 19-9 are often elevated but are not diagnostically useful since they lack sensitivity and specificity [15]. CA 19-9 can also be raised in any cholestatic condition (cholangitis, choledocholithiasis) and other GI cancers (pancreatic, gastric, colorectal) [5]. However, a markedly elevated or rising CA 19-9 in a known biliary cyst should raise suspicion for malignant transformation. |
| CEA | Adjunctive marker | Similarly non-specific. Serial assay after resection might aid in diagnosis of persistent or recurrent disease [15]. |
| AFP | Differentiate from HCC | If an intrahepatic cystic lesion is found, AFP helps distinguish cholangiocarcinoma (AFP usually normal) from HCC (AFP often elevated) [5]. |
Tumour Markers — Know Their Limitations
CA 19-9 and CEA are not useful as screening tools for malignancy in biliary cysts. They lack both sensitivity and specificity. A normal CA 19-9 does not exclude cholangiocarcinoma. Their main role is in monitoring after surgical excision — a rising level post-operatively suggests recurrence.
| Test | When to order | Why |
|---|---|---|
| Blood culture | If cholangitis suspected (fever + jaundice + RUQ pain) | Identify causative organism and guide antibiotic therapy [16] |
| RFT (Renal function) | Pre-operative workup; if sepsis suspected | Assess for hepatorenal syndrome, contrast-induced nephropathy risk, sepsis-related AKI |
| Stool for ova and parasites | Hong Kong / endemic area [4] | Screen for Clonorchis sinensis which may co-exist with biliary cysts and contribute to cholangitis |
2. Radiological Investigations
This is the core of biliary cyst diagnosis. Let me walk through each modality in the logical order you'd use clinically:
Why USG first?
- Non-invasive, no radiation, no contrast, readily available, cheap, can be done at bedside.
- Excellent for detecting biliary dilatation and gallstones.
Key Findings in Biliary Cysts:
| Finding | What It Tells You |
|---|---|
| Cystic, anechoic structure continuous with the bile duct | Confirms presence of a biliary cyst |
| Fusiform or saccular dilatation of the CBD | Type I cyst |
| Intrahepatic ductal dilatation with cystic areas | Type IVa or V |
| Dilated CBD ( > 8 mm) [9] | Biliary obstruction — but need to distinguish true cyst from reactive dilatation |
| Gallstones within the cyst | Cystolithiasis (complication) |
| Sludge/echogenic material in the cyst | Stasis, possible infection |
Limitations of USG [1]:
- Results affected by patient's body habitus, presence of bowel gas, and limited visualisation due to overlying structures [1].
- Frequently misses Type III choledochal cysts [1] — because the choledochocele is located in the intraduodenal (intramural) segment of the distal CBD, which is deep in the retroperitoneum behind the duodenum, where bowel gas obscures the view.
- Cannot reliably demonstrate APBJ.
- Cannot fully characterise intrahepatic disease (Type IVa, V).
- Operator-dependent [10].
In neonates:
- USG is the first-line investigation for conjugated neonatal jaundice.
- Must distinguish from biliary atresia: contracted GB + triangular cord sign = biliary atresia [6]; cystic dilatation of bile duct = choledochal cyst [6].
CBD normal limits (exam pearl from senior notes): CBD limit: 0.1 cm for every 10 years old [17]. So a 60-year-old can have a CBD of up to 6 mm normally. Post-cholecystectomy, the CBD may dilate by 1–2 mm as the bile duct assumes a reservoir function. CBD > 8 mm is generally considered pathological [9][17].
When to use:
- When transabdominal USG is equivocal or limited.
- When Type III (choledochocele) is suspected — EUS provides excellent visualisation of the intraduodenal distal CBD.
- To assess the cyst wall for mural nodularity or solid components (malignancy screening).
- To evaluate the pancreaticobiliary junction.
Key Advantages:
- Demonstrates extrahepatic biliary cysts and provides detailed images of the cyst wall and pancreaticobiliary junction [1].
- NOT limited by body habitus, bowel gas, or overlying structures [1].
- Can guide FNA if there is a suspicious solid component.
Limitations:
- Requires endoscopy (invasive, sedation needed).
- Cannot assess intrahepatic ducts as well as MRCP.
- EUS cannot reach the lumen of the bile duct in majority of cases [15] — so for detailed cholangiography, MRCP or ERCP is needed.
This is the single most important investigation for biliary cysts. Let me explain why from first principles.
What is MRCP?
- Non-contrast, T2-weighted MRI sequence [17].
- T2-weighted images make fluid appear bright white (hyperintense). Since bile is fluid, the entire biliary tree "lights up" on T2 sequences, creating a beautiful cholangiogram without needing to inject any contrast.
- "MR" = magnetic resonance; "CP" = cholangiopancreatography ("cholangio-" = bile duct, "pancreat-" = pancreas, "-graphy" = imaging).
Why is MRCP the test of choice? [1]
| Advantage | Explanation |
|---|---|
| Confirms that the cysts communicate with the biliary tree | This is the defining feature that distinguishes a biliary cyst from a hepatic cyst, pancreatic cyst, or other non-biliary lesion |
| Delineates the full biliary anatomy | Shows the exact type (Todani classification), extent of intrahepatic involvement, and relationship to hepatic duct confluence |
| Demonstrates APBJ | Can show the long common channel where the pancreatic duct joins the CBD outside the duodenal wall — critical for operative planning and malignancy risk assessment |
| Does NOT expose patients to ionising radiation | Especially important in children (most biliary cysts present < 10 years) |
| Does not have risks of cholangitis and pancreatitis associated with ERCP [1] | ERCP injects contrast under pressure into the biliary tree, risking cholangitis and post-ERCP pancreatitis. MRCP avoids this entirely. |
| Non-invasive | No sedation required (in older children/adults). No endoscopy. |
Key MRCP Findings in Biliary Cysts:
| Finding | Todani Type | Interpretation |
|---|---|---|
| Fusiform/saccular CBD dilatation with communication to biliary tree | Type I | Most common finding |
| Diverticulum off the CBD | Type II | Rare; side-pocket projecting from duct |
| Intraduodenal cystic lesion communicating with distal CBD | Type III | Choledochocele |
| Both intra- and extrahepatic cystic dilatation | Type IVa | Assess extent of intrahepatic involvement for operative planning |
| Multiple extrahepatic cysts only | Type IVb | Less common |
| Multiple saccular intrahepatic dilatations communicating with bile ducts | Type V | Caroli disease; look for "central dot sign" (better on CT) |
| Long common channel with pancreatic duct joining CBD > 1 cm from ampulla | APBJ | Present in 70–90%; critical prognostic and operative finding |
| Mural nodularity / irregularity within the cyst | Malignancy | Suggests cholangiocarcinoma arising within the cyst; requires further workup |
When to use:
- After MRCP has confirmed and classified the cyst.
- Pre-operative planning: anatomy, extent, vascular relationships, and malignancy screening.
Key CT Findings:
| Finding | Significance |
|---|---|
| Detects all types of biliary cysts including determining intrahepatic disease in patients with Type IV and V [1] | Full anatomical mapping |
| Demonstrates continuity of cyst with biliary tree [1] | Confirms biliary origin |
| Examines relationship of cyst to surrounding structures [1] | Vascular anatomy (hepatic artery, portal vein) — essential for safe surgical excision |
| Evaluates for presence of malignancy [1] | Enhancing mural nodule, soft tissue mass within or adjacent to cyst, lymphadenopathy, liver metastases |
| "Central dot sign" (Caroli disease) | Portal vein radicle surrounded by dilated intrahepatic duct — pathognomonic for Type V |
| Calcification within cyst wall | Chronic cyst; raises concern for malignant transformation |
Limitations:
- Radiation exposure (relevant in children — minimise if possible).
- Less detailed biliary anatomy compared to MRCP.
- Not useful for detecting gallstones (only 75% of gallstones identified on CT [17]).
Biliary cysts should be differentiated from cysts that do NOT communicate with the biliary tree including pancreatic, mesenteric and hepatic cysts [1]. This is the single most important interpretation point on imaging.
What is ERCP?
- An endoscopic procedure where a duodenoscope is passed to the ampulla of Vater, the bile duct is cannulated, and contrast is injected under fluoroscopy to visualise the biliary tree.
- "Endoscopic" = via endoscope; "Retrograde" = contrast flows backwards (upstream) from the ampulla; "Cholangio-" = bile duct; "Pancreat-" = pancreas; "-graphy" = imaging.
Role in Biliary Cysts:
- Largely replaced by MRCP as a diagnostic tool [15].
- Still useful when:
- Therapeutic intervention is needed: biliary stenting for cholangitis, sphincterotomy for Type III cyst.
- Brush cytology is needed to evaluate for cholangiocarcinoma.
- MRCP is contraindicated (e.g., MRI-incompatible implant) or equivocal.
Key Findings on ERCP:
- Cholangiogram shows the cystic dilatation and its relationship to the biliary tree.
- Can demonstrate APBJ (long common channel).
- Can identify stones within the cyst.
- Brush cytology of the cyst wall for malignant cells.
Risks of ERCP (why we prefer MRCP):
- Post-ERCP pancreatitis (3–5% risk) — contrast injection into the pancreatic duct.
- Cholangitis — introduction of bacteria into an obstructed system.
- Perforation of the duodenum or bile duct.
- Bleeding after sphincterotomy.
When to use:
- Preferred to ERCP when obstruction is at or above the level of confluence of hepatic ducts [17] — because ERCP approaches from below (retrograde) and cannot easily pass proximal high-grade obstructions.
- Useful in Type IVa with high intrahepatic obstruction.
- Can be combined with percutaneous transhepatic biliary drainage (PTBD) for decompression.
Complications: Bacteraemia (thus antibiotic prophylaxis required), haemobilia [17].
What is it?
- HIDA = Hepatobiliary Iminodiacetic Acid scan. A nuclear medicine study where a technetium-99m-labelled IDA compound is injected IV, taken up by hepatocytes, and excreted into bile.
- You then image the abdomen with a gamma camera to follow the tracer through the biliary tree.
Role in Biliary Cysts:
- Primarily used in neonates to differentiate biliary cyst from biliary atresia.
- In biliary atresia: absence of isotope in the intestine [6] (no biliary excretion at all).
- In biliary cyst: Isotope accumulates in the cyst and may eventually reach the intestine (unless completely obstructed).
- Pre-treatment with 5 days of phenobarbitone (a liver enzyme inducer that increases biliary secretion) improves the sensitivity of the test [6].
- Gold standard for confirming the diagnosis in paediatric surgery settings [6].
- Performed intra-operatively: contrast is injected directly into the biliary tree via the cystic duct or gallbladder during surgery.
- Delineates the cyst anatomy in real-time, confirms communication with the biliary tree, identifies APBJ, and guides the extent of excision.
- Especially important in neonates where pre-operative imaging may be inconclusive.
| Step | Modality | Purpose | Key Findings |
|---|---|---|---|
| 1. Screen | USG | Initial diagnostic modality | Cystic dilatation of bile duct; exclude gallstones; assess GB |
| 2. Define | MRCP | Test of choice for anatomy | Confirm cyst communicates with biliary tree; classify Todani type; demonstrate APBJ |
| 3. Stage | CT | Determine extent + exclude malignancy | Intrahepatic involvement; vascular anatomy; mural nodules; lymphadenopathy; metastases |
| (If needed) | EUS | Distal/equivocal lesions; cyst wall assessment | Type III characterisation; FNA of suspicious nodule |
| (If needed) | ERCP | Therapeutic (stent, sphincterotomy) or tissue sampling | Decompression for cholangitis; brush cytology; Type III treatment |
| (Neonates) | HIDA scan | Differentiate from biliary atresia | Isotope reaches intestine = NOT biliary atresia |
| (Intra-op) | Operative cholangiogram | Gold standard confirmation | Real-time biliary anatomy; confirms APBJ; guides excision |
3. Special Considerations
In a neonate with conjugated jaundice, the diagnostic pathway is specifically designed to differentiate biliary cyst from biliary atresia as rapidly as possible:
For any patient with a known biliary cyst (especially Type I or IVa, and especially if age > 20), you must actively look for malignant transformation:
| Investigation | Finding Suggesting Malignancy |
|---|---|
| CT with contrast | Enhancing solid component / mural nodule within the cyst; lymphadenopathy; liver metastases |
| MRCP | Irregularity of cyst wall; stricture within adjacent bile duct |
| EUS + FNA | Cytology showing malignant cells from cyst wall nodule |
| ERCP + brush cytology | Malignant cells on biliary brushings |
| CA 19-9 | Markedly elevated or rapidly rising (though non-specific) |
| PET-CT | FDG-avid lesion within the cyst wall |
High Yield Exam Points
- USG = Diagnostic; MRCP = Anatomy; CT = Extent — this is the investigation triad for biliary cysts [2].
- MRCP is the test of choice — confirms biliary communication, classifies type, demonstrates APBJ, no radiation, no risk of cholangitis/pancreatitis [1].
- USG frequently misses Type III cysts due to bowel gas obscuring the intraduodenal segment [1].
- Blood tests are often normal in uncomplicated biliary cysts [1].
- In neonates, the critical DDx is biliary atresia — HIDA scan (absence of intestinal isotope) and operative cholangiogram (gold standard) differentiate the two [6].
- CA 19-9 and CEA are not diagnostically useful for screening but are used for monitoring after excision [15].
- Always assess for APBJ and malignancy as part of the diagnostic workup — these dictate the surgical approach and urgency.
Active Recall - Diagnosis and Investigation of Biliary Cysts
[1] Senior notes: felixlai.md (Biliary cysts — Diagnosis and Radiological tests sections) [2] Senior notes: maxim.md (Choledochal cyst — Investigations section) [4] Senior notes: maxim.md (Recurrent pyogenic cholangitis section) [5] Senior notes: maxim.md (Cholangiocarcinoma — Investigations section); felixlai.md (Cholangiocarcinoma — Diagnosis section) [6] Senior notes: maxim.md (Hepatobiliary conditions — paediatric table: biliary atresia and choledochal cyst) [9] Senior notes: maxim.md (Choledocholithiasis section) [10] Senior notes: maxim.md (Biliary colic — USG findings section) [15] Senior notes: felixlai.md (Malignant biliary obstruction — Biochemical tests section; Gallbladder cancer — Tumour markers section) [16] Senior notes: maxim.md (Acute cholangitis section) [17] Senior notes: maxim.md (HBP investigations section)
Management of Biliary Cysts
Before diving into the specifics, understand the fundamental logic behind treating biliary cysts:
- Biliary cysts are pre-malignant. The lifetime risk of cholangiocarcinoma is 10–30% and increases with age. This is the single most compelling reason for definitive surgery [1].
- Conservative observation is NOT acceptable for most types. Unlike simple hepatic cysts (which can be watched), biliary cysts have ongoing exposure to pancreatic juice reflux (via APBJ) that causes progressive epithelial damage and malignant transformation.
- Internal drainage procedures (cyst-enterostomy) are obsolete. Older operations that simply drained the cyst into the bowel (without excising it) left the diseased epithelium in situ — the malignancy risk persisted or even increased. Modern management demands complete excision of the cyst [2].
- The gallbladder must also be removed. Because APBJ affects the entire biliary epithelium including the gallbladder, and the gallbladder is in the surgical field. Prophylactic cholecystectomy is indicated in patients with APBJ but no biliary cysts because of the increased risk of gallbladder cancer [1].
Treatment by Todani Type — Detailed Breakdown
This is the most common type and the paradigm for biliary cyst surgery. Understanding this operation well means you understand all the others.
What is done:
Type I = Complete surgical excision + Roux-en-Y hepaticojejunostomy [1]
- Complete excision of the cyst: The entire dilated extrahepatic bile duct (cyst) is removed, from the hepatic duct confluence above down to the intrapancreatic CBD below. The cystic epithelium — which harbours the pre-malignant potential — is completely eliminated.
- Cholecystectomy: The gallbladder is removed because (a) the cystic duct inserts into or near the cyst, and (b) APBJ exposes gallbladder epithelium to pancreatic juice → increased gallbladder cancer risk.
- Roux-en-Y Hepaticojejunostomy (HJ): A loop of jejunum is divided, the distal limb (the "Roux limb") is brought up to the hepatic duct stump and anastomosed end-to-side. The proximal limb is reconnected to the jejunum further downstream (jejunojejunostomy), creating the characteristic "Y" shape.
Why Roux-en-Y?
Let me break down the name:
- Roux = César Roux, Swiss surgeon who devised this technique.
- en-Y = "in [the shape of] Y" (French).
- Hepatico- = hepatic duct; -jejunostomy = surgical connection to jejunum.
The Roux-en-Y configuration is chosen over simpler options (like choledochoduodenostomy) because:
| Advantage | Explanation |
|---|---|
| Prevents bile reflux | The long Roux limb (typically ≥ 40 cm) creates a conduit long enough that duodenal content and food cannot reflux up to the biliary anastomosis. This prevents ascending cholangitis and further epithelial damage. |
| Reconstruction required to provide biliary drainage from the liver [1] | After the entire extrahepatic duct is excised, bile has nowhere to go. The Roux limb provides a new pathway for bile to reach the intestine. |
| Reduced stricture risk | The wide mouth of the hepaticojejunostomy is less prone to stricture than a direct duct-to-duodenum anastomosis [2]. |
Why not just drain the cyst into the duodenum (internal drainage)?
Historically, cyst-enterostomy (e.g., cystoduodenostomy or cystojejunostomy) was performed — creating a window between the cyst and bowel without removing the cyst. This is now obsolete because:
- The cyst epithelium remains in situ → ongoing malignancy risk (actually increased risk due to intestinal reflux into the cyst).
- Biliary stasis within the residual cyst → stone formation → recurrent cholangitis.
- Studies showed cholangiocarcinoma rates of up to 30% in patients with undrained/internally drained cysts.
Due to significant risk of malignancy and cyst excision can reduce complications such as recurrent cholangitis, cystolithiasis, choledocholithiasis and pancreatitis [1]
Long-term complications of Roux-en-Y HJ:
Most frequent long-term complication of Roux-en-Y hepatojejunostomy is stenosis of biliary-enteric anastomosis leading to jaundice, cirrhosis or cholangitis [1]
This occurs because:
- Any surgical anastomosis heals by scar tissue formation.
- The biliary-enteric junction is particularly prone to cicatricial (scar) narrowing because: (a) small calibre of the hepatic duct; (b) bile is a relatively corrosive fluid; (c) ischaemia at the suture line.
- Stricture → bile stasis → recurrent cholangitis → secondary biliary cirrhosis.
- Prevention: Meticulous surgical technique with tension-free, well-vascularised, mucosa-to-mucosa anastomosis.
Type II = Simple excision of cysts [1]
- Type II cysts are diverticula — true outpouchings (side pockets) from the CBD wall.
- The diverticulum is excised and the defect in the CBD wall is closed primarily (sutured).
- Extensive resection reserved for cysts with complicated presentations including jaundice or malignancy in the cyst [1].
- Because these are rare (2–3% of biliary cysts), the malignancy risk is lower, and a simple excision is usually sufficient.
Type III = Endoscopic sphincterotomy [1]
This is the exception to the rule of surgical excision. Why?
- Type III = choledochocele = cystic dilatation of the intraduodenal (intramural) portion of the distal CBD.
- The cyst protrudes into the duodenal lumen.
- It has the lowest malignancy risk of all Todani types.
- Surgical excision would require duodenotomy and potentially damage the pancreatic duct, which shares the common ampulla.
Procedure:
- Endoscopic snare resection can be performed for Type IIIA cyst (cyst lined by biliary epithelium) [1].
- Surgical or endoscopic resection can be performed for Type IIIB cyst (cyst lined by duodenal epithelium) [1].
- Endoscopic sphincterotomy effectively "unroofs" the cyst, allowing free drainage of bile into the duodenum and decompressing the choledochocele.
Type III is the Only Type Managed Endoscopically
This is an exam favourite. All other types require surgical excision. Type III is the exception because: (1) low malignancy risk, (2) intraduodenal location amenable to endoscopic access, (3) surgery would risk pancreatic duct injury.
Type IV = Complete surgical excision + Roux-en-Y hepatojejunostomy [1]
Type IV is subdivided into IVa (intra- + extrahepatic) and IVb (multiple extrahepatic only):
Type IVa (more common, more complex):
- Patients with intrahepatic cysts (Type IVA) require partial hepatectomy for excision of cyst and reconstruction with wide hilar Roux-en-Y hepatojejunostomy [1].
- The extrahepatic cyst is excised just as in Type I.
- For intrahepatic cysts: if confined to one lobe (usually left), a formal hepatectomy (left hepatectomy most commonly) is performed to excise the intrahepatic cystic disease entirely.
- If intrahepatic disease is bilateral but resectable, staged procedures or extensive hepatectomy with portal vein embolisation (to grow the future liver remnant) may be required.
- A wide hilar anastomosis is created to drain all remaining intrahepatic ducts into the Roux limb.
Type IVb (multiple extrahepatic only):
- Managed as for Type I — complete excision of all extrahepatic cysts + Roux-en-Y HJ.
Type V = Supportive + Liver transplantation [1]
This is the most difficult type to manage because the cystic disease is purely intrahepatic and often diffuse:
Unilateral disease (confined to one lobe):
- Caroli disease can be treated with hemihepatectomy when it is confined to one side of the lobe [1].
- Left lobe involvement is more common → left hepatectomy.
- Curative if all diseased liver is removed.
Bilateral / diffuse disease:
- Treatment is largely supportive and is aimed at dealing with problems such as recurrent cholangitis and sepsis [1].
- Supportive measures include:
- Antibiotics for episodes of cholangitis.
- Ursodeoxycholic acid (UDCA) to improve bile flow and reduce stone formation.
- ERCP/PTBD for stone clearance and drainage of infected segments.
- Patients with bilateral disease may eventually need a liver transplantation [1].
- Liver transplantation is the definitive cure for diffuse Caroli disease/syndrome, especially if complicated by:
- Recurrent intractable cholangitis.
- Secondary biliary cirrhosis with portal hypertension.
- Associated congenital hepatic fibrosis (Caroli syndrome).
- Suspicion of cholangiocarcinoma (if still within transplant criteria).
| Type | Surgery | Key Details |
|---|---|---|
| I | Complete excision + Cholecystectomy + Roux-en-Y HJ | Most common operation. Remove all cyst epithelium. |
| II | Simple diverticulum excision + CBD repair | Extensive resection if malignancy/complications |
| III | Endoscopic sphincterotomy ± snare resection | Only type managed endoscopically. Lowest malignancy risk. |
| IVa | Complete excision + Partial hepatectomy + Wide hilar Roux-en-Y HJ | Must address intrahepatic cysts with hepatectomy |
| IVb | Complete excision + Roux-en-Y HJ | As for Type I |
| V unilateral | Hemihepatectomy | Curative if confined to one lobe |
| V bilateral | Supportive + Liver transplantation | Definitive cure for diffuse disease |
Management of Acute Complications (Before Definitive Surgery)
Definitive surgery should never be performed in the setting of active sepsis/cholangitis. The acute complication must be managed first.
The approach follows the same "RAD" framework used for any acute cholangitis [16]:
Management of cholangitis: Resuscitation → Antibiotics → Drainage [18][19]
| Step | Action | Details |
|---|---|---|
| R — Resuscitation | NPO, IV fluids, monitor vitals and I/O [16] | Septic patients need aggressive fluid resuscitation. Correct coagulopathy (IV Vitamin K). Correct electrolyte abnormalities. |
| A — Antibiotics | IV Augmentin (mild) or IV Tazocin (severe) [16] | Broad-spectrum coverage against Gram-negatives (E. coli, Klebsiella) + anaerobes. Adjust based on culture results. |
| D — Drainage | Biliary decompression | Urgent if Reynolds pentad (shock + confusion) or failure to respond to antibiotics within 24 hours [16]. |
Biliary Drainage Options for Acute Cholangitis:
| Modality | Indication | Mechanism |
|---|---|---|
| ERCP + biliary stenting (1st line) [19][20] | Standard first-line approach. Endoscopic retrograde cholangiopancreatography ± biliary stenting [20]. Role: biliary drainage and decompression, NOT definitive stone removal at this stage [16]. | Stent placed across the obstruction to allow bile to drain into the duodenum, decompressing the infected biliary tree. |
| PTBD [16][18] | Indicated when ERCP is unsuccessful, unavailable, or contraindicated [21]. | Percutaneous transhepatic approach to drain bile externally. Useful when ERCP cannot access proximal intrahepatic disease. |
| Surgical drainage (ECBD) [20] | Failure of endoscopic drainage or deterioration despite endoscopic drainage [20]. Open approach for emergency case [20]. | Exploration of common bile duct with T-tube placement for decompression. High mortality (~30%) in emergency setting — last resort [16]. |
QMH practice: ERCP → PTBD → ECBD [3]
Relative Contraindications for ERCP
Altered GI anatomy e.g. Billroth II gastrectomy, Roux-en-Y [20] — the side-viewing duodenoscope cannot reach the ampulla if the anatomy has been surgically altered. In these patients, use PTBD or surgical drainage instead.
- Supportive management: NPO, IV fluids, analgesia, monitor for organ failure.
- ERCP only if there is concurrent cholangitis or persistent biliary obstruction.
- Definitive cyst excision deferred until pancreatitis resolves.
Special Scenarios
Prophylactic cholecystectomy is indicated in patients with APBJ but no biliary cysts because of the increased risk of gallbladder cancer [1].
Why? Because APBJ allows pancreatic juice reflux into the gallbladder even when the bile duct itself is not cystically dilated. This chronic chemical insult to the gallbladder epithelium increases gallbladder cancer risk. Cholecystectomy removes the at-risk organ.
- Intra-operative frozen section should be performed on the cyst wall and any suspicious areas during excision [5].
- If cholangiocarcinoma is confirmed:
- The operation is converted to an oncological resection: extended hepatectomy, bile duct resection, portal lymph node dissection, and reconstruction with Roux-en-Y HJ.
- Adjuvant chemotherapy may be considered post-operatively.
- Even if asymptomatic, surgical excision is recommended for all types except Type III (which can be observed if small and asymptomatic).
- The malignancy risk is age-dependent and cumulative — waiting only increases the risk.
- The only exception is the patient who is unfit for surgery (advanced age, severe comorbidities), in whom the risks of surgery outweigh the benefits.
- Surgery is ideally deferred to the second trimester (if symptomatic) or post-partum.
- If cholangitis develops during pregnancy, drainage (ERCP or PTBD under radiation-minimised technique) and antibiotics should be instituted first.
Since this is the reconstruction used in the majority of biliary cyst surgeries, let me detail it further:
Key surgical points:
- The Roux limb must be long enough (≥ 40 cm) to prevent reflux of enteric content to the biliary anastomosis.
- The anastomosis should be tension-free and well-vascularised (checking for pink, bleeding mucosa at the anastomotic edge).
- Mucosa-to-mucosa suturing technique is essential for optimal healing and patency.
- A wide hilar anastomosis is critical when reconstructing Type IVa cysts — all residual intrahepatic ducts must drain into the Roux limb.
After definitive surgery, patients require lifelong surveillance because:
- Anastomotic stricture — the most common long-term complication [1].
- Residual intrahepatic disease — particularly in Type IVa where complete intrahepatic excision may not be possible.
- Cholangiocarcinoma risk persists (albeit reduced) — malignancy can arise in any residual biliary epithelium, including the bile duct stump at the anastomosis.
| Surveillance Component | Frequency | Purpose |
|---|---|---|
| LFT | 6–12 monthly | Detect anastomotic stricture (rising ALP/GGT/bilirubin) |
| CA 19-9 | 6–12 monthly | Serial assay after resection to aid in diagnosis of persistent or recurrent disease [15] |
| USG abdomen | Annually | Detect intrahepatic stone formation, abscess, recurrent dilatation |
| MRCP | As needed / every 2–3 years | Assess anastomotic patency, residual intrahepatic disease |
| CT/MRI with contrast | If suspicion of malignancy | Evaluate for cholangiocarcinoma |
| Scenario | Management Modification |
|---|---|
| Active cholangitis/sepsis | Treat sepsis first (RAD). Surgery deferred until patient stabilised. |
| Confirmed cholangiocarcinoma within the cyst | Oncological resection (not simple cyst excision). May require extended hepatectomy + LN dissection + adjuvant chemotherapy. |
| Patient unfit for major surgery (elderly, severe comorbidities) | For Type III: endoscopic management is sufficient. For others: ERCP/PTBD for drainage + surveillance if surgery risk is prohibitive. Consider palliative stenting. |
| Roux-en-Y reconstruction not feasible (hostile abdomen, prior extensive surgery) | Alternatives: choledochoduodenostomy (higher reflux risk — less preferred) or hepaticoduodenostomy. Roux-en-Y remains the gold standard when technically possible. |
| Bilateral diffuse Caroli disease | Liver transplantation is the only curative option. Surgery alone cannot excise all disease. |
Complete excision of cyst and GB; Reconstruction with Roux-en-Y hepaticojejunostomy [6]
- In neonates, the key differential is biliary atresia. Once choledochal cyst is confirmed (operative cholangiogram), proceed to excision + reconstruction.
- Surgery can be performed safely in infants. Minimally invasive (laparoscopic or robotic) approaches are increasingly used in paediatric centres.
- Post-operative: long-term follow-up for anastomotic stricture and growth/nutritional monitoring.
High Yield Summary — Management of Biliary Cysts
- All biliary cysts (except Type III) require surgical excision — to prevent cholangiocarcinoma, recurrent cholangitis, and stone formation.
- Type I and IVb: Complete cyst excision + cholecystectomy + Roux-en-Y hepaticojejunostomy.
- Type II: Simple excision of diverticulum.
- Type III: Endoscopic sphincterotomy ± snare resection (only type managed endoscopically; lowest malignancy risk).
- Type IVa: Complete excision + partial hepatectomy (for intrahepatic cysts) + wide hilar Roux-en-Y HJ.
- Type V unilateral: Hemihepatectomy. Bilateral: Supportive + liver transplantation.
- APBJ without cyst: Prophylactic cholecystectomy (increased gallbladder cancer risk).
- Internal drainage (cyst-enterostomy) is obsolete — leaves pre-malignant epithelium in situ.
- Most common long-term complication: Anastomotic stricture of the biliary-enteric anastomosis.
- Acute cholangitis: Treat first with RAD (Resuscitation, Antibiotics, Drainage) before definitive surgery.
Active Recall - Management of Biliary Cysts
References
[1] Senior notes: felixlai.md (Biliary cysts — Treatment section) [2] Senior notes: maxim.md (Choledochal cyst — Management section) [3] Senior notes: felixlai.md (Acute cholangitis — Treatment section: QMH practice) [4] Senior notes: maxim.md (Recurrent pyogenic cholangitis section) [5] Senior notes: maxim.md (Gallbladder carcinoma — Treatment section; Cholangiocarcinoma — Management section) [6] Senior notes: maxim.md (Hepatobiliary conditions — paediatric table: choledochal cyst) [15] Senior notes: felixlai.md (Malignant biliary obstruction — Tumour markers section) [16] Senior notes: maxim.md (Acute cholangitis — Acute management RAD section) [18] Lecture slides: Malignant biliary obstruction.pdf (p15, p17) [19] Lecture slides: GC 200. RUQ pain, jaundice and fever Cholecytitis and cholangitis Imaging of GI system.pdf (p14) [20] Lecture slides: GC 200. RUQ pain, jaundice and fever Cholecytitis and cholangitis Imaging of GI system.pdf (p15) [21] Senior notes: felixlai.md (Percutaneous transhepatic biliary drainage section)
Complications of Biliary Cysts
Complications of biliary cysts can be divided into two broad categories:
- Complications of the disease itself (i.e., the untreated or partially treated biliary cyst).
- Complications of surgical treatment (i.e., post-operative complications of cyst excision and Roux-en-Y reconstruction).
Understanding the complications from first principles means tracing each one back to the core pathophysiology we have already established: biliary stasis, APBJ with pancreatic reflux, chronic epithelial inflammation, and the anatomical mass effect of the cyst.
A. Complications of the Disease (Untreated Biliary Cyst)
These are the complications listed in the source notes [1][22]:
Complications of biliary cysts [1]:
- Cholangiocarcinoma
- Acute cholangitis
- Acute and chronic pancreatitis
- Stone formation (cystolithiasis, hepatolithiasis, cholelithiasis, choledocholithiasis)
- Intraperitoneal cyst rupture
- Secondary biliary cirrhosis
- Bleeding
- Gastric outlet or duodenal obstruction
Let me now explain each one in detail with its pathophysiological basis.
Cholangiocarcinoma (CC) [1][2] — this is the single most feared and most important complication of biliary cysts. It is the reason we operate on biliary cysts even when they are asymptomatic.
Pathophysiology:
The malignant transformation follows a metaplasia → dysplasia → carcinoma sequence:
- APBJ allows chronic reflux of activated pancreatic enzymes (trypsin, phospholipase A₂, elastase) into the biliary tree.
- These enzymes cause continuous chemical injury to the biliary epithelium lining the cyst.
- The epithelium responds with hyperproliferation (attempting to repair the damage) and undergoes intestinal metaplasia (the biliary epithelium transforms to resemble intestinal epithelium — a more robust mucosa to "defend" itself).
- Over time, genetic mutations accumulate in the rapidly dividing cells (p53 loss, K-ras mutations, CDKN2A inactivation).
- Metaplastic epithelium progresses through low-grade dysplasia → high-grade dysplasia → invasive adenocarcinoma.
Key clinical points:
| Feature | Detail |
|---|---|
| Lifetime risk | 10–30% in untreated biliary cysts |
| Risk increases with age | Especially after 20 years of age; incidence peaks in 4th–6th decades |
| Highest risk types | Type I and Type IV [1]; also APBJ without overt cyst |
| Histology | > 90% are adenocarcinoma [5] |
| Location | Can arise within the cyst wall itself, in the biliary tree beyond the cyst, or even in the gallbladder (due to APBJ affecting entire biliary epithelium) |
| After incomplete excision | Malignancy can arise in residual cyst epithelium — this is why internal drainage (cyst-enterostomy) is obsolete |
| After complete excision | Risk is reduced but not eliminated — can still develop in residual intrahepatic ducts or at the biliary-enteric anastomosis |
Red flags for malignant transformation in a known biliary cyst:
- New-onset or worsening painless jaundice
- Rapid weight loss
- Rising or markedly elevated CA 19-9
- Mural nodularity or solid component within the cyst on imaging
- New liver lesion(s) suspicious for metastasis
Cholangiocarcinoma is Why We Operate
Never observe a biliary cyst (except Type III) hoping it will "behave." The malignancy risk is cumulative and age-dependent. Every year of delay increases the chance of cholangiocarcinoma developing. Complete excision is preventive surgery — analogous to removing a colonic adenoma before it becomes cancer.
Acute cholangitis [1]
Pathophysiology:
- Cystic dilatation creates a sump where bile pools and stagnates (poor "flushing" mechanism).
- Stagnant bile is an excellent culture medium for bacteria, particularly Gram-negative bacilli (E. coli, Klebsiella) which reach the biliary tree via:
- Ascending infection from the duodenum (especially if APBJ bypasses the sphincter of Oddi barrier).
- Haematogenous spread from portal venous blood.
- Obstruction (from the cyst itself, or from stones formed within the cyst) prevents drainage of infected bile.
- Result: Charcot's triad (fever, RUQ pain, jaundice) → if severe, Reynolds pentad (+ shock + confusion) — suppurative cholangitis with bacteraemia.
Clinical significance:
- Cholangitis is the most common acute presentation that brings adults with biliary cysts to medical attention.
- Recurrent cholangitis causes cumulative biliary epithelial damage, accelerating the metaplasia–dysplasia–carcinoma sequence.
- Management: RAD (Resuscitation, Antibiotics, Drainage) before definitive surgery [16].
Acute and chronic pancreatitis [1]
Pathophysiology:
- APBJ creates a long common channel that allows bidirectional reflux — not only can pancreatic juice flow into the biliary tree, but bile can also reflux into the pancreatic duct.
- Bile reflux into the pancreatic duct activates pancreatic proenzymes (trypsinogen → trypsin) within the pancreas, triggering autodigestion → acute pancreatitis.
- Passage of stones from the cyst through the common channel can also cause transient obstruction of the pancreatic duct orifice → pancreatitis (analogous to gallstone pancreatitis).
- Repeated episodes of acute pancreatitis can lead to chronic pancreatitis with fibrosis, duct stricturing, exocrine/endocrine insufficiency.
Stone formation [1]:
- Cystolithiasis (stones and sludge forming within the cyst itself)
- Hepatolithiasis (intrahepatic stone formation)
- Cholelithiasis (gallstones)
- Choledocholithiasis (CBD stones)
Pathophysiology:
- Biliary stasis within the dilated cyst allows precipitation of bile components — calcium bilirubinate, cholesterol, and bile salts crystallise out of supersaturated, stagnant bile.
- Bacterial infection (particularly E. coli, Klebsiella) produces bacterial β-glucuronidase, which deconjugates bilirubin glucuronide → unconjugated bilirubin → combines with calcium → calcium bilirubinate (brown pigment) stones [4].
- This is exactly the same mechanism as in recurrent pyogenic cholangitis (RPC) [4].
- Stones cause further obstruction → more stasis → more stone formation → a vicious cycle.
Intraperitoneal cyst rupture [1]
Pathophysiology:
- The cyst wall is inherently abnormal — thinned, weakened, and damaged by chronic inflammation and pancreatic enzyme exposure.
- In neonates and infants, the cyst wall is particularly fragile.
- Elevated intracystic pressure (from obstruction, infection, or simply progressive dilatation) can cause the cyst to rupture into the peritoneal cavity.
- Bile spillage into the peritoneal cavity causes bile peritonitis — a chemical peritonitis caused by the cytotoxic and pro-inflammatory effects of bile salts and bilirubin on the peritoneal mesothelium.
- If infected bile leaks, this becomes secondary bacterial peritonitis — a surgical emergency.
Clinical features of cyst rupture:
- Sudden onset of severe diffuse abdominal pain.
- Signs of peritonitis: guarding, rigidity, rebound tenderness.
- Haemodynamic instability if significant.
- Abdominal free fluid on USG/CT.
- Emergency laparotomy is required.
Secondary biliary cirrhosis (due to prolonged biliary obstruction and recurrent cholangitis) [1]
Pathophysiology:
- Chronic, sustained biliary obstruction (from the cyst itself or from complications such as stones and strictures) causes cholestasis.
- Cholestasis → retention of bile acids within hepatocytes → hepatocyte injury (bile acid toxicity).
- Concurrent recurrent cholangitis causes periductal inflammation and fibrosis around intrahepatic bile ducts.
- Over months to years, progressive fibrosis bridges portal tracts → cirrhosis (secondary biliary cirrhosis).
- Cirrhosis leads to portal hypertension → splenomegaly, ascites, variceal bleeding, hepatorenal syndrome.
- In Caroli syndrome (Type V), congenital hepatic fibrosis compounds this — patients may develop portal hypertension even before secondary biliary cirrhosis develops.
This is exactly the same mechanism seen in any cause of chronic biliary obstruction (e.g., PSC, strictures, malignant obstruction).
Bleeding (due to erosion of the cyst into adjacent vessels or due to portal hypertension) [1]
Two mechanisms:
| Mechanism | Pathophysiology |
|---|---|
| Cyst erosion into vessels | Chronic inflammation and enzymatic damage from pancreatic reflux can erode the cyst wall into adjacent vascular structures (e.g., hepatic artery branches, portal vein branches, gastroduodenal artery). This is analogous to a pseudoaneurysm forming adjacent to chronic pancreatitis. Can present as haemobilia (bleeding into the biliary tree → melaena, haematemesis, or blood clots causing biliary obstruction). |
| Portal hypertension | If secondary biliary cirrhosis has developed → portal hypertension → oesophageal/gastric varices → variceal bleeding. Also: splenomegaly → thrombocytopenia → coagulopathy → increased bleeding risk. |
Gastric outlet or duodenal obstruction (due to obstruction of duodenal lumen) [1]
Pathophysiology:
- A large extrahepatic cyst (especially Type I or Type III) can exert external compression on the adjacent duodenum (D1/D2).
- In Type III (choledochocele), the cyst protrudes into the duodenal lumen itself, directly causing intraluminal obstruction.
- Presents with: nausea, vomiting (especially post-prandial), early satiety, gastric distension.
- In severe cases, complete gastric outlet obstruction requiring nasogastric decompression and urgent surgery.
B. Post-operative Complications (After Cyst Excision + Roux-en-Y HJ)
Even after successful surgery, patients are at risk for specific complications. These are divided into early and late categories:
| Complication | Pathophysiology | Presentation | Management |
|---|---|---|---|
| Biliary anastomotic leak | Failure of the hepaticojejunostomy suture line — ischaemia, tension, technical error. | Bile-stained drain output, fever, RUQ pain, peritonitis, rising bilirubin post-op day 2–10. | Minor: ERCP stent or percutaneous drain. Major: re-laparotomy + lavage + repair ± revision of anastomosis [23]. |
| Haemorrhage | Intra-operative vascular injury (hepatic artery, portal vein branches close to the cyst), or post-operative bleeding from raw surfaces. | Haemodynamic instability, dropping Hb, abdominal distension. | Resuscitation, transfusion, angiographic embolisation or re-exploration. |
| Post-operative cholangitis | Bacterial contamination of a freshly reconstructed biliary tree, especially if pre-operative drainage was in situ (stent colonisation). | Fever, rigors, jaundice in early post-op period. | Blood cultures, IV antibiotics (Augmentin/Tazocin), ensure anastomotic patency on imaging. |
| Wound infection / Intra-abdominal abscess | Standard surgical complication of any major abdominal surgery. | Wound erythema/discharge; or persistent fever + localised collection on CT. | Antibiotics ± percutaneous or surgical drainage. |
| Pancreatitis | Manipulation near the pancreaticobiliary junction during cyst excision, especially the intrapancreatic portion of the CBD. | Epigastric pain, elevated amylase/lipase. | Supportive: NPO, IV fluids, analgesia. |
| Complication | Pathophysiology | Presentation | Management |
|---|---|---|---|
| Anastomotic stricture (most frequent long-term complication) [1] | Scar tissue formation at the hepaticojejunostomy. The biliary-enteric junction is prone to cicatricial narrowing due to small calibre, exposure to bile (corrosive), and potential ischaemia. | Progressive jaundice, cholestatic LFTs (rising ALP/GGT/bilirubin), recurrent cholangitis. Onset months to years post-operatively. | Percutaneous balloon dilatation of stricture via established access; revision hepaticojejunostomy if refractory [1]. |
| Recurrent cholangitis | Anastomotic stricture → stasis proximal to the narrowing → bacterial colonization. Or reflux of enteric content up the Roux limb if the limb is too short ( < 40 cm). | Recurrent episodes of fever, jaundice, RUQ pain. | Antibiotics for acute episode; investigate for stricture (MRCP); revision surgery or balloon dilatation. |
| Intrahepatic stone formation | Residual intrahepatic ductal dilatation (especially in incompletely excised Type IVa) → stasis → stone formation. | Cholangitis, RUQ pain, rising LFTs. | PTBD for stone clearance; hepatectomy for localised disease. |
| Cholangiocarcinoma in residual biliary epithelium | Malignant transformation can still occur in residual intrahepatic ducts or at the anastomotic stump even after complete extrahepatic cyst excision. Risk is reduced but not zero. | New painless jaundice, weight loss, rising CA 19-9, new liver lesion on surveillance imaging. | Oncological resection if feasible; palliative care if unresectable. |
| Secondary biliary cirrhosis | Long-standing anastomotic stricture → chronic biliary obstruction → cirrhosis over years. | Signs of chronic liver disease: jaundice, ascites, spider naevi, variceal bleeding. | Liver transplantation if end-stage. |
| Adhesive small bowel obstruction | Any major abdominal surgery creates adhesions. The Roux limb and jejunojejunostomy create additional peritoneal surfaces that can form adhesions. | Colicky abdominal pain, vomiting, distension, absolute constipation. | Conservative initially (NGT, IV fluids); laparotomy/laparoscopy if failed conservative or signs of strangulation. |
Caroli disease deserves special mention because its complications are more severe and complex than other types:
| Complication | Details |
|---|---|
| Recurrent cholangitis (hallmark) | The most common presentation of Caroli disease. Multiple saccular dilatations in intrahepatic ducts act as stagnant pools → recurrent infection. Refractory to antibiotic therapy alone. |
| Intrahepatic abscess | Progression from cholangitis — infected bile within dilated intrahepatic ducts ruptures into surrounding liver parenchyma → pyogenic liver abscess [22]. May spread to lungs and brain via haematogenous route. |
| Hepatolithiasis | Extensive intrahepatic stone formation due to chronic stasis. |
| Portal hypertension | In Caroli syndrome (with congenital hepatic fibrosis) — fibrosis causes pre-sinusoidal portal hypertension even without cirrhosis. Manifests as splenomegaly, variceal bleeding, ascites. |
| Cholangiocarcinoma | Risk is elevated in Caroli disease due to chronic biliary inflammation and stasis. |
| Renal complications | Caroli syndrome is associated with ARPKD — patients may develop renal failure requiring dialysis or renal transplantation alongside liver transplantation. |
Since ERCP is used for drainage of acute cholangitis complicating biliary cysts and for treating Type III cysts, its complications are relevant [19][20]:
Potential complications of ERCP: perforation, bleeding from papillotomy, pancreatitis [20]
| Complication | Incidence | Mechanism | Key Points |
|---|---|---|---|
| Post-ERCP pancreatitis | ~2–5% | Most frequent complication [24]. Manipulation/injection of contrast into pancreatic duct → oedema of pancreatic orifice → outflow obstruction → autodigestion. | Presents with epigastric pain and elevated amylase/lipase post-procedure. Usually mild and self-limiting. Prevention: rectal indomethacin, pancreatic duct stent. |
| Cholangitis / Flare-up sepsis | ~1% | Injection of contrast into an obstructed system introduces bacteria and increases intraluminal pressure → bacteraemia. | Aspirate bile first before injecting contrast to decompress. Antibiotic prophylaxis recommended. |
| Post-sphincterotomy bleeding | ~2% | Electrocautery incision through the sphincter cuts through submucosal vessels. | Risk increased with coagulopathy. Managed with injection (adrenaline), clipping. |
| Perforation | ~1% | Retroperitoneal perforation (cutting too far during sphincterotomy — into the retroperitoneal portion of the duodenum). Intraperitoneal perforation if scope perforates duodenal wall. | Retroperitoneal: conservative management (seals off). Intraperitoneal: surgical repair needed. |
| Stent occlusion/migration | Late | Sludge, biofilm, or tumour ingrowth (uncovered stents) → blocked stent → recurrent obstruction/cholangitis. | Scheduled stent change for plastic stents. Metallic stents have longer patency [23]. |
| Category | Complications |
|---|---|
| Malignant | Cholangiocarcinoma (most important; 10–30% lifetime risk) |
| Infective | Acute cholangitis, liver abscess, biliary sepsis |
| Inflammatory | Acute/chronic pancreatitis |
| Obstructive | Stone formation (cystolithiasis, hepatolithiasis, cholelithiasis, choledocholithiasis), gastric outlet/duodenal obstruction, secondary biliary cirrhosis |
| Mechanical | Intraperitoneal cyst rupture → bile peritonitis |
| Vascular | Bleeding (erosion into vessels, portal hypertension) |
| Post-surgical | Anastomotic stricture (most common late), bile leak (early), recurrent cholangitis, residual cholangiocarcinoma |
High Yield Summary — Complications of Biliary Cysts
- Cholangiocarcinoma is the most important complication — 10–30% lifetime risk, highest in Types I and IVa, risk increases with age. This is the primary reason for surgical excision.
- Acute cholangitis is the most common acute complication — due to biliary stasis and bacterial colonization. Treat with RAD before definitive surgery.
- Pancreatitis occurs because of bidirectional reflux through APBJ (bile → pancreatic duct).
- Stone formation follows the same mechanism as RPC: biliary stasis + bacterial glucuronidase → brown pigment stones.
- Cyst rupture causes bile peritonitis — surgical emergency, especially in neonates.
- Secondary biliary cirrhosis results from chronic obstruction ± recurrent cholangitis.
- Post-operatively, anastomotic stricture is the most frequent long-term complication of Roux-en-Y hepaticojejunostomy → leads to jaundice, cirrhosis, or cholangitis.
- Even after complete excision, cholangiocarcinoma risk persists (reduced but not zero) in residual intrahepatic epithelium → lifelong surveillance required.
Active Recall - Complications of Biliary Cysts
References
[1] Senior notes: felixlai.md (Biliary cysts — Complications section) [2] Senior notes: maxim.md (Choledochal cyst — Complications section) [4] Senior notes: maxim.md (Recurrent pyogenic cholangitis — Pathophysiology section) [5] Senior notes: felixlai.md (Cholangiocarcinoma — Pathogenesis section) [16] Senior notes: maxim.md (Acute cholangitis — Acute management RAD section) [19] Lecture slides: GC 200. RUQ pain, jaundice and fever Cholecytitis and cholangitis Imaging of GI system.pdf (p14) [20] Lecture slides: GC 200. RUQ pain, jaundice and fever Cholecytitis and cholangitis Imaging of GI system.pdf (p15) [22] Senior notes: felixlai.md (RPC — Complications section) [23] Senior notes: maxim.md (Cholecystectomy — Specific complications section) [24] Senior notes: felixlai.md (ERCP — Complications section)
High Yield Summary
Must-know points for biliary cysts:
- Definition: Congenital cystic dilatations of the biliary tree (intra- and/or extrahepatic).
- Epidemiology: Female predominance (1:3–4), common in Asians, most diagnosed before age 10.
- Aetiology: APBJ present in 70–90% → allows pancreatic juice reflux → epithelial damage → cyst formation and malignant transformation.
- Todani Classification: Type I (most common, ~50–80%), Type IVa (2nd most common), Type V = Caroli disease.
- Classic triad: Jaundice + abdominal pain + abdominal mass (more common in children; only ~20–30% of adults).
- Malignancy risk: 10–30% lifetime risk of cholangiocarcinoma, highest in Types I and IVa, risk increases with age.
- Hong Kong relevance: APBJ common in Asians; Clonorchis sinensis adds synergistic risk; RPC is a related condition.
- Caroli disease = Type V = intrahepatic cystic dilatation. Caroli syndrome = + congenital hepatic fibrosis + ARPKD.
- Type III (choledochocele) has the lowest malignancy risk.
- Treatment (preview): Radical excision + Roux-en-Y hepaticojejunostomy to prevent cholangiocarcinoma.
High Yield Summary — Differential Diagnosis of Biliary Cysts
When confronted with a cystic biliary lesion:
- Age: Young → biliary cyst, biliary atresia (neonate). Old → malignant obstruction, pancreatic cyst.
- APBJ present? → Strongly favours biliary cyst.
- Does the cyst communicate with the bile duct? → Yes = biliary cyst or Caroli disease. No = hepatic cyst, hydatid, pancreatic cyst.
- Acquired vs. congenital: History of pancreatitis (pseudocyst), surgery (post-op dilatation), parasites (RPC).
- MRCP is the single most useful investigation to resolve the differential — it delineates ductal anatomy, cyst communication, and APBJ in one study.
High Yield Exam Points
- USG = Diagnostic; MRCP = Anatomy; CT = Extent — this is the investigation triad for biliary cysts [2].
- MRCP is the test of choice — confirms biliary communication, classifies type, demonstrates APBJ, no radiation, no risk of cholangitis/pancreatitis [1].
- USG frequently misses Type III cysts due to bowel gas obscuring the intraduodenal segment [1].
- Blood tests are often normal in uncomplicated biliary cysts [1].
- In neonates, the critical DDx is biliary atresia — HIDA scan (absence of intestinal isotope) and operative cholangiogram (gold standard) differentiate the two [6].
- CA 19-9 and CEA are not diagnostically useful for screening but are used for monitoring after excision [15].
- Always assess for APBJ and malignancy as part of the diagnostic workup — these dictate the surgical approach and urgency.
High Yield Summary — Management of Biliary Cysts
- All biliary cysts (except Type III) require surgical excision — to prevent cholangiocarcinoma, recurrent cholangitis, and stone formation.
- Type I and IVb: Complete cyst excision + cholecystectomy + Roux-en-Y hepaticojejunostomy.
- Type II: Simple excision of diverticulum.
- Type III: Endoscopic sphincterotomy ± snare resection (only type managed endoscopically; lowest malignancy risk).
- Type IVa: Complete excision + partial hepatectomy (for intrahepatic cysts) + wide hilar Roux-en-Y HJ.
- Type V unilateral: Hemihepatectomy. Bilateral: Supportive + liver transplantation.
- APBJ without cyst: Prophylactic cholecystectomy (increased gallbladder cancer risk).
- Internal drainage (cyst-enterostomy) is obsolete — leaves pre-malignant epithelium in situ.
- Most common long-term complication: Anastomotic stricture of the biliary-enteric anastomosis.
- Acute cholangitis: Treat first with RAD (Resuscitation, Antibiotics, Drainage) before definitive surgery.
High Yield Summary — Complications of Biliary Cysts
- Cholangiocarcinoma is the most important complication — 10–30% lifetime risk, highest in Types I and IVa, risk increases with age. This is the primary reason for surgical excision.
- Acute cholangitis is the most common acute complication — due to biliary stasis and bacterial colonization. Treat with RAD before definitive surgery.
- Pancreatitis occurs because of bidirectional reflux through APBJ (bile → pancreatic duct).
- Stone formation follows the same mechanism as RPC: biliary stasis + bacterial glucuronidase → brown pigment stones.
- Cyst rupture causes bile peritonitis — surgical emergency, especially in neonates.
- Secondary biliary cirrhosis results from chronic obstruction ± recurrent cholangitis.
- Post-operatively, anastomotic stricture is the most frequent long-term complication of Roux-en-Y hepaticojejunostomy → leads to jaundice, cirrhosis, or cholangitis.
- Even after complete excision, cholangiocarcinoma risk persists (reduced but not zero) in residual intrahepatic epithelium → lifelong surveillance required.
Acute Pancreatitis
Acute inflammatory condition of the pancreas caused by premature activation of pancreatic enzymes, leading to autodigestion, edema, and potentially hemorrhagic necrosis of pancreatic tissue.
Cholangiocarcinoma
Cholangiocarcinoma is a malignant neoplasm arising from the epithelial cells of the intrahepatic or extrahepatic bile ducts, often presenting with obstructive jaundice and carrying a poor prognosis.